IGC Pharma, Inc.
IGCNYSEAMERICANHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $24.68M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.24$0.45
- Volume (live)
- -
- Avg. volume (3M)
- 599.86K
IGC Pharma (IGC) Stock Price & Financial Analysis
IGC Pharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.25 - $0.25 |
|---|---|
| 52-Week High | $0.45 |
| 52-Week Low | $0.24 |
| Open | $0.25 |
| Volume (last close) | 124.24K |
| Average Volume (3M) | 599.86K |
| Revenue (TTM) | 1.25M |
|---|---|
| Net Income (TTM) | -7.66M |
| Free Cash Flow (TTM) | -5.40M |
| EPS (TTM) | −$0.08 |
| Profit Margin | -613.53% |
| Operating Margin | -807.69% |
| Return on Equity (ROE) | -124.97% |
| Debt to Equity | 0.18 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 24.68M |
|---|---|
| Shares Outstanding | 100.33M |
| Price to Sales (P/S) | 19.76 |
| Price to Book (P/B) | 4.03 |
| EV/EBITDA | -2.47 |
| 50-Day MA | $0.28 |
|---|---|
| 200-Day MA | $0.28 |
| 1-Year Change | −34.30% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
IGC Pharma at a Glance
As of the Oct 23, 2026 close, IGC Pharma (IGC) has a market capitalization of $24.68M. The stock trades at 19.8× sales. Over the trailing twelve months it lost $7.66M on revenue of $1.25M and burned $5.40M of free cash flow. Revenue grew 12.9% year over year.
As of its latest reported balance sheet, it holds $331.00K in cash and securities against $1.09M of debt, a net debt position of $756.00K.
IGC Pharma does not currently pay a dividend.
The share price is down 34.3% over the past year. At $0.25 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $0.23 to $0.45, below its 200-day moving average of $0.28.
Frequently Asked Questions About IGC Pharma
What is the current stock price for IGC?
As of the Oct 23, 2026 close, IGC stock trades at $0.25. The 52-week range is $0.24–$0.45, with a day range of $0.25–$0.25.
What is the P/E ratio for IGC?
The P/E ratio (Price-to-Earnings) for IGC is shown in the Key Statistics section. This valuation metric helps compare IGC Pharma, Inc. to industry peers.
Does IGC pay dividends?
IGC Pharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for IGC?
Analyst ratings and recommendations for IGC are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of IGC?
As of the Oct 23, 2026 close, IGC Pharma's market capitalization is $24.7M, classifying it as a micro-cap company. IGC Pharma operates in the Healthcare sector within the Biotechnology industry.